Stomach balloon systems market seen reaching $2.26 billion by 2030

The global stomach balloon systems market is projected to grow from $1.43 billion in 2025 to $1.57 billion in 2026, driven by rising obesity rates and demand for non-surgical weight loss options. The Business Research Company says the market could reach $2.26 billion by 2030 as minimally invasive procedures, digital monitoring and new balloon technologies gain traction.

Why it matters: - The stomach balloon systems market is tied to the global obesity treatment market, which is expanding as more adults seek medically supervised weight-loss options. - The category offers a non-surgical alternative to bariatric surgery, which can broaden access for patients and clinics looking for lower-risk procedures. - The market’s growth signals stronger demand for minimally invasive and outpatient weight-management care.

What happened: - The Business Research Company published its Stomach Balloon Systems Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Sept. 11, 2026. - The report puts the market at $1.43 billion in 2025 and $1.57 billion in 2026. - The report forecasts the market will reach $2.26 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow fastest during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report also includes key technologies and future trend analysis.

The details: - Stomach balloon systems, also called intragastric balloons, are soft balloons inserted into the stomach and filled with saline or gas. - The procedure reduces stomach capacity, which helps patients feel full sooner and eat less. - The report says historical growth has been driven by rising obesity rates, stronger demand for non-surgical weight-loss options, wider bariatric healthcare infrastructure, greater awareness of metabolic disorders and improved endoscopic safety. - The report says future growth will be supported by AI-powered patient monitoring systems, biodegradable gastric balloon technologies, combination treatments that include anti-obesity medications, telehealth follow-up care and more personalized metabolic treatment. - The report identifies growing use of swallowable gastric balloons, minimally invasive endoscopic bariatric procedures, adjustable and longer-lasting intragastric balloons, remote digital monitoring after procedures and outpatient-based bariatric care as major trends. - Obesity is defined in the report as excessive body fat accumulation, typically with a body mass index of 30 or more. - The World Obesity Federation projected in March 2025 that about 3 billion adults, or roughly half of the global adult population, will be overweight or obese by 2030. - The US National Library of Medicine reported in September 2023 that 7,733 robotic surgical systems had been installed worldwide and more than 10 million robotic surgeries had been performed. - The report presents the market as a growing segment within obesity treatment, with demand linked to lifestyle-related weight gain and the search for less invasive therapies. - The report provides contact information for The Business Research Company and offers a free sample and full report online: Download a free sample and View the full report.

Between the lines: - The forecast points to a market shifting from niche obesity intervention toward broader use as care moves into less invasive, more data-driven treatment models. - The strongest growth themes are technological, not just clinical, with monitoring software, swallowable devices and telehealth follow-up shaping the next phase of adoption. - North America's current lead suggests established healthcare infrastructure, while faster growth in Asia-Pacific points to expanding demand in newer markets.

What's next: - The market’s next stage will likely depend on how quickly manufacturers commercialize biodegradable balloons, swallowable systems and integrated monitoring tools. - Adoption will also hinge on whether clinics continue moving weight-loss care into outpatient and telehealth settings. - The report signals continued competition around convenience, safety and long-term weight-management outcomes.